stocks logo

CTOR Stock Price Prediction

Citius Oncology Inc
$
0.670
+0.010(+1.520%)
  • Overview
  • Forecast
  • Valuation

Should I Buy Citius Oncology Inc Stock?

Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. CTOR has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.

CTOR stock price ended at $0.67 on Wednesday, after rising 1.52%

The Citius Oncology Inc stock price increased by 1.52% on the last trading day (Wednesday Apr 2025), rising from 0.651 to 0.67. Throughout the last trading session, the stock experienced a fluctuation of 6.22% , ranging from a day low of $0.64 to a day high of 0.6798. The price has declined in 5 of the last 10 days, resulting in a total change of -2.05% during this period. On the last day, trading volume increase by -18.68K shares, with the rising prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 25.75K  shares were traded, amounting to approximately 16.84K.

CTOR Technical Signals

CTOR(Citius Oncology Inc Corp) has 0 buy signals and 4 sell signals now. The current trend is uptrend starting from 2025-04-04. The total price change during this trend is -2.91%. Recently, the price has increased but the volume has decreased, indicating a potential warning signal. The average turnover of CTOR over the last 5 trading days is 27.88K. Overall, the technical indicator signals lean more toward a Bearish outlook in the mid-term.

CTOR Moving Average Analysis

Citius Oncology Inc's overall moving average trend leans more bearish as of Thursday, April 24, 2025, with 3 negative signals and 1 positive signal. In the mid-term, the SMA_20 being below the SMA_60 signals a strong bearish trend. There will be some resistance from the lines at $0.75, and $0.8. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $0.58, and $0.53. A break-down below any of these levels will issue sell signals.

CTOR Short Selling Analysis

The short sale ratio of Citius Oncology Inc(CTOR) as of 22 Apr 2025 is 3.51%, dropping from last trading day. With decreasing price from 0.62 to 0.66. The short sell activity indicate that short sellers may be experiencing short cover.

Technical Signals Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Strong sell
Sell
4
Buy
0

Moving Average

Swing

up ImagePositive

Stock Price Above SMA_5

Short Term

down ImageNegative

SMA_5 Below SMA_20

Mid Term

down ImageNegative

SMA_20 Below SMA_60

Long Term

down ImageNegative

SMA_60 Below SMA_200

Short Selling

Close Price
Short Sale Ratio
Short Sale Volume
0 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
No Data
4 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish

Indicators

Signal

Value

Meaning

Awesome Oscillator (5, 34)

AO_5_34 < 0

-0.07

Bearish

Momentum (10 days)

MOM_10 < 0

-0.01

Bearish

Moving Average Convergence Divergence (12, 26, 9)

MACD_12_26_9 < 0

-0.05

Bearish

Moving Average

5-day SMA crosses below 10-day SMA

--

Bearish

CTOR Price Prediction & Forecast by Similar Chart Analysis

Based on historical patterns and backtesting of stocks with similar movements to Citius Oncology Inc(CTOR), our algorithm predicts CTOR's 1-month price at $0.72, with an 7.73%upwardshift. Using a similarity score up to 94.83%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for Citius Oncology Inc (CTOR.O) stock, as of Sunday, April 13, 2025 , forecasts a 7.73% change over the next month, based on its high correlation with MLR.N stock patterns. The similarity between their price movements over the analyzed periods is 94.83%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
stocks logo

CTOR

Future prediction

Up: 7.73%

stocks logo

MLR

Up: 7.73%Similarity: 94.83%

Name

Similarity

Up/Down

stocks logo

MLR.N

94.83%

+7.73%

stocks logo

ECOR.O

94.79%

+6.62%

stocks logo

UEC.A

94.46%

+8.68%

stocks logo

FDX.N

94.25%

-2.37%

stocks logo

HPH.O

94.23%

-58.85%

stocks logo

ATHE.O

94.22%

-16.42%

stocks logo

COCP.O

94.19%

-1.67%

stocks logo

STEM.N

93.95%

-35.14%

stocks logo

SQNS.N

93.84%

-14.59%

stocks logo

FCNCA.O

93.67%

+12.61%

CTOR Seasonality Analysis

Based on CTOR's historical stock price data across all years, the probability of a positive return in April is66.67%, suggesting it maybe an ideal month to invest in CTOR. In contrast,Januaryoffers the highest probability of positive returns at100.00%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.

Monthly Seasonality

The radar chart shows that buying Citius Oncology Inc (CTOR.O) stock in January has the highest probability of a positive return (100.00%), while June has the lowest probability (50.00%).

Performance Seasonality

The chart shows Citius Oncology Inc. (CTOR)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.

FAQ

arrow icon

Should I buy Citius Oncology Inc (CTOR.O) stock?

Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. CTOR has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.

arrow icon

Which months have the highest win rate for buying Citius Oncology Inc (CTOR.O) stock in a year?

arrow icon

How has Citius Oncology Inc. (CTOR)'s stock price performed over the past three years?

arrow icon

Which bull technical signals does CTOR have?

arrow icon

Which bearish technical signals does CTOR have?

arrow icon

Is CTOR a buy based on overall technical signals summary?

arrow icon

What is the trend of Citius Oncology Inc (CTOR)'s moving average?

arrow icon

What is price prediction for CTOR stock next month?

arrow icon

arrow icon